SLNO
Soleno Therapeutics, Inc.Healthcare$39.49
◆ Neutral
Mkt Cap: $2.12B|Float: 47.9M|SI: 19.5%|DTC: 5.8
Data as of market close Apr 2, 2026
IV Rank
83
IV Pctl
56%
HV 20d
91.0%
52W Range
$29-$90
ATR(14)
$2.40
Exp. Move
±15.1%
P/C Ratio
1.21
Earnings
May 6
GEX Positive
DEX Long
Net Call Premium
IV High
Max Pain Below
Exp. Move Wide
High Put/Call
SLNO Key Options Data
- IV Rank
- 83.4%
- Total GEX
- $0.00B
- Total DEX
- $1.5M
- Max Pain
- $30.00
- Expected Move
- ±15.1%
- Put/Call OI
- 1.21
- Net Premium
- $0.3M
- Spot Price
- $39.49
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$5.97 | ±15.1% | $33.52 | $45.47 |
| 2026-05-15 | 43 | ±$9.60 | ±24.3% | $29.89 | $49.09 |
| 2026-06-18 | 77 | ±$12.60 | ±31.9% | $26.89 | $52.09 |
| 2026-09-18 | 169 | ±$20.60 | ±52.2% | $18.89 | $60.09 |
| 2027-01-15 | 288 | ±$22.30 | ±56.5% | $17.19 | $61.79 |
Explore SLNO options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.